Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

PHARMACEUTICAL INDUSTRY

The pharmaceutical industry operates under unique circumstances: Estimates of the cost to bring a single new drug to market range from $800 million to $1.2 billion, and on average, a patent’s life remaining upon FDA launch approval is only eight years. Thus, achieving the highest level of performance is critical to pharmaceutical companies. This topic is dedicated to marketing, market research, business operations, and management issues specific to the pharmaceutical industry.

Pharmaceutical Industry is part of Business Exchange, suggested by Ken Rhines. This topic contains 2,453 news and 2,581 blog items. Read updated news, blogs, and resources about Pharmaceutical Industry. Find user-submitted articles and reactions on Pharmaceutical Industry from like-minded professionals.

Most Active

The most active stories in this topic based on user activity.

Glaxo Puts Hold on Some Swine Flu Shots in Canada (Update1)more

Nov. 23 (Bloomberg) -- Canadian doctors should hold off on using a batch of GlaxoSmithKline Plc’s swine flu vaccine...

Outsourcing Clinical Research - Clinical trials Phase 1 trials, Resear...more

The law of nature shows a dependence of various species of living beings on each other which is primarily a survival...

Novartis' Sullivan on cross-border dealmaking (Dealscapemore

Marvelle Sullivan, the head of corporate legal M&A at Novartis AG (NYSE:NVS), spoke at The Deal Economy 2010...

Big Pharma conclude M&A is not the new R&Dmore

World leaders meet at the illustrious NGP Summit in Florida to face up to economic woes.

The blogopharmasphere?more

http://www.the-scientist.com/blog/display/56142/

Pfizer slashing R&D footprint by 35% more

Pfizer Inc. (NYSE:PFE) employees concerned about their jobs may have a better idea of where they stand.

Breast Cancer Vaccine Tests German Merck’s $1 Billion Strategymore

Nov. 4 (Bloomberg) -- Merck KGaA of Germany is gambling an unproven therapy that spurs the immune system to attack...

J&J chief calls job cuts 'difficult'more

Two weeks after Johnson & Johnson (NYSE:JNJ) reported mixed earnings, which tugged stocks downward, the world's...

Linklaters' Schmidt on Pfizer-Wyeth reviewmore

The approval by U.S. antitrust regulators of Pfizer Inc.'s (NYSE:PFE) acquisition of Wyeth is an outlier of how merger...

New Drug Development (NCE) - Clinical trials Phase 1 trials, Research ...more

Placebos are getting more "effective". It sounds absurd but many "clinical studies "in the world of...

Lilly CEO Lechleiter Calls for Repair of the 'Engine of Biopharma Inno...more

SAN DIEGO, Oct. 30 /PRNewswire-FirstCall/ -- In a speech today to the City Club of San Diego, John C. Lechleiter, Ph.D.

Generics - Clinical trials Phase 1 trials, Research blog of Veeda Grou...more

The Indian generic market has been plagued with reports of Indian counterfeit medicines getting sold in important...

Glaxo Search for Acquisitions Hampered by ‘Desperate’ Rivalsmore

Sept. 25 (Bloomberg) -- GlaxoSmithKline Plc’s search outside its own laboratories for new drugs is getting more...

Cancer - Clinical trials Phase 1 trials, Research blog of Veeda Groupmore

A "2" way approach to business The Cancer Health forecasts are very promising and are expected to grow at a...

H1N1 is now world's dominant flu virus, World Health Organization saysmore

The H1N1 virus has now become the dominant influenza virus around the globe, with high levels and an increase of...

Pharmaceutical Industry Set to Emerge as winners in the Healthcare Ref...more

Once a powerful profit-machine, big pharma is stumbling ,the threat of further government intervention, drying product...

300 reasons CME is evolvingmore

My, how far CME has come in the age of technology! It seems like just yesterday that CME was in the infancy stage of...

Onyx Pharma dealmakers build M&A culturemore

When Onyx Pharmaceuticals Inc. (NASDAQ:ONXX) bought Proteolix Inc. on Oct. 12, (The Deal Pipeline subscription...

Indian Pharma - Clinical trials Phase 1 trials, Research blog of Veeda...more

An explicit indicator of the government intervention in the Corporate strategies of Indian companies is a headliner in...

78 percent of US interested in mobile healthcare solutionsmore

78 percent of US interested in mobile healthcare solutions

Epeius Biotechnologies to Partner at BIO Investor Forum - Funding and ...more

SAN FRANCISCO, Calif., Oct. 20 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corporation, an emerging leader in the...

What are the top three challenges facing the pharma supply chain inmore

I am in the process of developing LogiPharma 2010, a conference for supply chain and logistics decision makers in the...

Doozy of a Day One for Pfizer-Wyeth R&Dmore

On Wednesday, Pfizer Inc. (NYSE:PFE) received approval from the FTC for its $68 billion acquisition of Wyeth.

Vaccines are Hotmore

The race to offer H1N1 flu vaccination is picking up pace. While global H1N1 vaccine manufacturers like Sanofi Pasteur,...

U.S. Drug Companies Chase Vaccinesmore

Amid rising flu concerns, three big drug companies have formed deals that give them rights to new vaccines.

Topic Feed: Most active content in Pharmaceutical Industry

Top Sources: Pharmaceutical Industry

  • BusinessWeek
  • srcomblog.wordpress.com
  • New York Times
  • bloomberg.com
  • Health Beat
  • Reuters
  • The Atlantic Business Channel
  • 247wallst.com
  • online.wsj.com
  • blogs.forbes.com

Most Active Users in this Topic

see all contributors...

Featured White Papers

Tweets on this Topic


Report comment contains invalid characters. ()
cancel
Search Cancel